Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Welcome and Introduction to Vi3C

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Opening Session Panel Discussion

Advertisement

Advertisement




Feb
05
Today In Oncology
New European Project Cluster EARLYSCAN Launched to Advance Early Detection of Heritable Cancers
First-Line mFOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type mCRC
WHO Analysis Finds Many Global Cancer Cases Attributable to Modifiable Risk Factors
Addition of Palbociclib to Standard Therapy in Hormone Receptor–Positive, HER2-Positive Metastatic Breast Cancer
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo